Northwest Biotherapeutics（股票代碼NWBO）股價財報分析

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient抯 own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Northwest Biotherapeutics股票代碼NWBO，員工數量20人，成立日期：。